NNE1

NNE1 is a drug that acts as a potent and selective agonist for the CB1 receptor, and was discovered during research into the related compound AM-694. NNE1 is part of the AM-2201 series, and is believed to be a CB1 agonist as well.

Chemistry

NNE1 is a synthetic cannabinoid that is also known as 1-(Naphthalen-1-yl)-2-(1-naphthylmethyl)-1H-indole-3-carboxamide. It is part of the AM-2201 series, which is a group of synthetic cannabinoids that are often used in research. The chemical structure of NNE1 is similar to that of other synthetic cannabinoids, but it has a unique naphthylmethyl group.

Pharmacology

NNE1 is believed to be a potent and selective CB1 receptor agonist, although the exact mechanism of action is not fully understood. It is thought to mimic the effects of cannabinoids in the body, which can lead to a range of effects including analgesia, sedation, and changes in mood.

Legal Status

The legal status of NNE1 varies by country. In some countries, it is classified as a controlled substance due to its potential for abuse and addiction. In others, it is legal for research purposes but not for human consumption.

See Also

• AM-2201
• CB1 receptor
• Synthetic cannabinoids

References

<references />

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia

NNE1

• 
  NNEI structure